Tetsuhiro Yoshinami

Suita, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 78 publications

Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10).

Randomised, multicentre phase II study of bevacizumab and paclitaxel induction followed by atezolizumab and nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer: protocol for the INDUCE trial (JBCRG-M10).

Journal: BMJ open
Published: May 13, 2026

Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort.

Phase II Trial of Nivolumab in Advanced Solid Tumors Based on Genomic Profiling: BELIEVE Trial (NCCH1901) Subcohort.

Journal: Cancer science
Published: April 07, 2026

Correction: Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study).

Correction: Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study).

Journal: Breast cancer (Tokyo, Japan)
Published: January 27, 2026

A Case Study of Severe Myelosuppression Induced by Adjuvant Chemotherapy in a Breast Cancer Patient with Concurrent Immune Thrombocytopenia(ITP)

A Case Study of Severe Myelosuppression Induced by Adjuvant Chemotherapy in a Breast Cancer Patient with Concurrent Immune Thrombocytopenia(ITP)

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 17, 2026

Health-related quality of life with pertuzumab retreatment: Secondary analysis of the PRECIOUS trial.

Health-related quality of life with pertuzumab retreatment: Secondary analysis of the PRECIOUS trial.

Journal: Breast (Edinburgh, Scotland)
Published: November 19, 2025

Impact of using intraoperative nomograms with one-step nucleic acid amplification to omit axillary lymph node dissection in patients with breast cancer who underwent mastectomy.

Impact of using intraoperative nomograms with one-step nucleic acid amplification to omit axillary lymph node dissection in patients with breast cancer who underwent mastectomy.

Journal: Cancer treatment and research communications
Published: October 12, 2025

Real-world outcomes of palbociclib plus endocrine therapy in elderly patients with HR+/HER2- advanced breast cancer in Japan: a subgroup analysis of the P-BRIDGE study by age group.

Real-world outcomes of palbociclib plus endocrine therapy in elderly patients with HR+/HER2- advanced breast cancer in Japan: a subgroup analysis of the P-BRIDGE study by age group.

Journal: Breast cancer (Tokyo, Japan)
Published: August 18, 2025

Isolated splenic metastasis presenting at diagnosis of HER2-positive de novo metastatic breast cancer: a case report.

Isolated splenic metastasis presenting at diagnosis of HER2-positive de novo metastatic breast cancer: a case report.

Journal: Journal of surgical case reports
Published: August 11, 2025

Effect of Tissue Sample Type on The Evaluation of PD-L1 (SP142) Expression in Breast Cancer.

Effect of Tissue Sample Type on The Evaluation of PD-L1 (SP142) Expression in Breast Cancer.

Journal: Anticancer research
Published: August 04, 2025

Analysis of PIK3CA mutations in the lysate of sentinel lymph nodes in patients with early breast cancer.

Analysis of PIK3CA mutations in the lysate of sentinel lymph nodes in patients with early breast cancer.

Journal: Frontiers in oncology
Published: July 03, 2025

Altered Estrogen Receptor Signaling Pathway in BRCA2-Deficient Estrogen Receptor-Positive/HER2-Negative Breast Cancer.

Altered Estrogen Receptor Signaling Pathway in BRCA2-Deficient Estrogen Receptor-Positive/HER2-Negative Breast Cancer.

Journal: Cancer reports (Hoboken, N.J.)
Published: June 29, 2025

A rare case of mastitis involving granulomatosis with polyangiitis after immune checkpoint inhibitor therapy.

A rare case of mastitis involving granulomatosis with polyangiitis after immune checkpoint inhibitor therapy.

Journal: International cancer conference journal
Published: June 28, 2025
Showing 1-12 of 78

Last Updated: 09/26/2026